| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/08/2004 | EP1453825A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor |
| 09/08/2004 | EP1453819A2 Statin-like compounds |
| 09/08/2004 | EP1453815A1 Metabotropic glutamate receptor-5 modulators |
| 09/08/2004 | EP1453811A2 Peroxisome proliferator activated receptor agonists |
| 09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 09/08/2004 | EP1453806A1 Aminotetralin derivatives as muscarinic receptor antagonist |
| 09/08/2004 | EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 09/08/2004 | EP1453804A2 Ccr-3 receptor antagonists vii |
| 09/08/2004 | EP1453803A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 09/08/2004 | EP1453800A2 Protein kinase inhibitors |
| 09/08/2004 | EP1453793A2 New pharmaceutical compounds |
| 09/08/2004 | EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453788A1 Substituted hydroxyethylamines |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453544A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453540A2 Modulation of lir function to treat rheumatoid arthritis |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453532A2 Taojiks as modifiers of the beta-catenin pathway and methods of use |
| 09/08/2004 | EP1453531A2 Use of hmgb proteins and nucleic acids that code therefor |
| 09/08/2004 | EP1453529A2 Treatment of sepsis with tafi |
| 09/08/2004 | EP1453528A2 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1453520A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/08/2004 | EP1453518A1 Pharmaceutical composition for the treatment of disorders of non-human mammals |
| 09/08/2004 | EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 09/08/2004 | EP1453513A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| 09/08/2004 | EP1453512A1 Acetylene derivatives having mglur 5 antagonistic activity |
| 09/08/2004 | EP1453511A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |
| 09/08/2004 | EP1453507A2 Solubilized topoisomerase poison agents |
| 09/08/2004 | EP1453504A1 Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation |
| 09/08/2004 | EP1453503A2 Ep4 receptor agonist, compositions and methods thereof |
| 09/08/2004 | EP1453499A1 Use of 2-hydroxy or 2-acetyloxy-4-trifluoro-methylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment |
| 09/08/2004 | EP1453498A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
| 09/08/2004 | EP1453497A1 Use for the treatment of gastroesophageal reflux disease |
| 09/08/2004 | EP1453496A2 Composition and method for modulating bar/fxr receptor activity |
| 09/08/2004 | EP1453495A2 Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1453431A2 Method and apparatus for the stimulation of hair growth |
| 09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
| 09/08/2004 | EP1292281B1 Novel tiotropium-containing inhalation powder |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1289950B1 Serine protease inhibitors |
| 09/08/2004 | EP1267853B1 Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease |
| 09/08/2004 | EP1254209A4 Bioavailable composition of natural and synthetic hca |
| 09/08/2004 | EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes |
| 09/08/2004 | EP1156057B1 Malto-oligosaccharide derivatives and uses thereof |
| 09/08/2004 | EP1156038B1 2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and processes for the preparation thereof |
| 09/08/2004 | EP1150746B1 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 09/08/2004 | EP1137662B1 Pharmaceutical compositions comprising quinapril magnesium |
| 09/08/2004 | EP1126870B1 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
| 09/08/2004 | EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 09/08/2004 | EP1089994B1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 09/08/2004 | EP1084119B1 Aromatic amine derivatives as pharmaceutical agents |
| 09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
| 09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
| 09/08/2004 | EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists |
| 09/08/2004 | EP0993456B1 2-substituted 4,5-diaryl imidazoles |
| 09/08/2004 | EP0991426B1 Method for transferring nucleic acid into the striated muscle |
| 09/08/2004 | EP0975370B9 Composition and method for enhancing transport across biological membranes |
| 09/08/2004 | EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 09/08/2004 | EP0729455B1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 09/08/2004 | CN1527836A Antiviral agents for treatment of flaviviridae infections |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
| 09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 09/08/2004 | CN1527822A Thiazole derivatives for treating PPAR related disorders |
| 09/08/2004 | CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527718A Method for short-term and long-term drug dosimetry |
| 09/08/2004 | CN1527717A Remedies |
| 09/08/2004 | CN1527713A Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 09/08/2004 | CN1527712A Active ingredient combination for medicamentous therapy of nicotine dependency |
| 09/08/2004 | CN1527711A Active substance combination for medicamentous therapy of habituation of or habitual material or narcotics |
| 09/08/2004 | CN1527707A The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 09/08/2004 | CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1527670A Aimal growth regulating composition and its prepn and use |
| 09/08/2004 | CN1526737A Molt-inhibiting hormone-1 protein of mitten crab |
| 09/08/2004 | CN1526448A Medicine and method for the treatment of anorectal disorders |
| 09/08/2004 | CN1526385A Ditropan hydrochloride dripping pills and the prepn process |
| 09/08/2004 | CN1165617C Oligonucleotides for inhibiting expression of human eg5 |
| 09/08/2004 | CN1165539C Oxazinocarbazoles for the treatment of CNS diseases |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 09/08/2004 | CN1165522C Bradykinin receptor antagonists |
| 09/08/2004 | CN1165518C Biocyclic amino acids compound compound as pharmaceutical agents |
| 09/08/2004 | CN1165340C Cartilage/bone inducing materials for reparation |
| 09/08/2004 | CN1165337C Synthetic cryptophycins |
| 09/08/2004 | CN1165336C Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/08/2004 | CN1165333C Compound body-strenghthening eucommia bark mixture for treating diseases caused by kidney Qi deficiency |